Iol Chemicals And Pharmaceuticals Limited

BSE: 524164 NSE: IOLCP
Iol Chemicals And Pharmaceuticals Limited - pharma in Barnala, Punjab, India. FY 2026 financials and compliance.
CIN L24116PB1986PLC007030 Incorporated 29 September 1986 ROC Chandigarh HQ Barnala, Punjab, India
Active Listed - NSE: IOLCP · BSE: 524164 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹2,319.06 Cr
▲ 11.54% YoY
Computed EBITDA · FY 2026
₹290.35 Cr
▲ 29.21% YoY
Net profit · FY 2026
₹137.64 Cr
▲ 36.18% YoY
Authorised capital
₹80 Cr
Registered with MCA
Paid-up capital
₹58.71 Cr
Issued & subscribed
Open charges
₹700 Cr
Satisfied ₹1,487.01 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
2,778
Latest available

About Iol Chemicals And Pharmaceuticals Limited

Data last updated: 15 July 2026

Iol Chemicals And Pharmaceuticals Limited is a public limited company based in Barnala, Punjab, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 29 September 1986, the company has been in operation for over 40 years.

Registered with ROC Chandigarh under CIN L24116PB1986PLC007030. Listed on BSE: 524164 and NSE: IOLCP.

Capital: an authorised share capital of ₹80 Cr and a paid-up capital of ₹58.71 Cr. Formerly known as Industrial Organics Limited and Trident Alco-Chem Limited. It is led by directors including Harpal Singh and Rajender Mohan Malla.

Last AGM: 22 August 2025. Financial statements filed for year ended 31 March 2025. Office: Village & Post Office – Handiaya Fatehgarh Chhanna Road Tehsil & District – Barnala, Punjab, India – 148107.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹2,319.06 Cr, a growth of 11.54% compared to the previous year. The net worth stands at ₹1,798.55 Cr (up 6.57% YoY). Total assets are valued at ₹2,586.95 Cr (up 8.6% YoY).

The company has a workforce of approximately 2,778 employees as per the latest available data. Its group structure includes 3 subsidiaries.

The company is associated with 1 brand - Iolcp. As per MCA filings, the company has open charges of ₹700 Cr and satisfied charges of ₹1,487.01 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website iolcp.com.

Company Details of Iol Chemicals And Pharmaceuticals Limited
CIN L24116PB1986PLC007030
Registration Number 007030
Incorporation Date 29 September 1986
ROC Chandigarh
Listing Status Listed (BSE: 524164, NSE: IOLCP)
Company Status Active
Date of Last AGM 22 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Varinder Gupta Managing Director Vikas Gupta Whole-Time Director Kushal Kumar Rana Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    iolcp.com
  • Social Media
  • Registered Address
    Village & Post Office – Handiaya Fatehgarh Chhanna Road Tehsil & District – Barnala, Punjab, India – 148107
  • Industry
    Pharma, API Manufacturers
Company report
Iol Chemicals And Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Iol Chemicals And Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Iol Chemicals And Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Iol Chemicals And Pharmaceuticals Limited

Iol Chemicals And Pharmaceuticals Limited has undergone 2 name changes throughout its history. The company was previously known as Industrial Organics Limited, and Trident Alco-Chem Limited. The current legal name is Iol Chemicals And Pharmaceuticals Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Iol Chemicals And Pharmaceuticals Limited Current
Industrial Organics Limited Previous
Trident Alco-Chem Limited Previous

CIN History of Iol Chemicals And Pharmaceuticals Limited

Iol Chemicals And Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): U24116PB1986PLC007030. The current CIN is L24116PB1986PLC007030, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24116PB1986PLC007030 Current
U24116PB1986PLC007030 Previous

Associated Brands with Iol Chemicals And Pharmaceuticals Limited

Iol Chemicals And Pharmaceuticals Limited operates one associated brand: IOLCP. These brands represent Iol Chemicals And Pharmaceuticals Limited's diversified market presence and brand portfolio.

Brand Description Website
IOLCP
Active pharmaceutical ingredients and specialty chemicals are manufactured. iolcp.com

Business Activity of Iol Chemicals And Pharmaceuticals Limited

Iol Chemicals And Pharmaceuticals Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Iol Chemicals And Pharmaceuticals Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Iol Chemicals And Pharmaceuticals Limited

Iol Chemicals And Pharmaceuticals Limited is audited by M/s. Ashwani & Associates, Chartered Accountants (ICAI peer reviewed, certificate valid till 2029-01-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s. Ashwani & Associates, Chartered Accountants (ICAI peer reviewed, certificate valid till 2029-01-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Iol Chemicals And Pharmaceuticals Limited

Iol Chemicals And Pharmaceuticals Limited is currently managed by 8 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Harpal Singh
Also directs: Success Steps Private Limited
Director 06 Feb 2019 7 Years 5 Months Current
Rajender Mohan Malla
Also directs: Aahaana Associates Llp, Vgrm Associates Llp, Filatex India Limited and 5 more
Director 06 Feb 2019 7 Years 5 Months Current
Varinder Gupta
Also directs: Iol Speciality Chemicals Limited, Mayadevi Polycot Limited, Nm Merchantiles Limited and 1 more
Managing Director 13 Nov 1986 39 Years 8 Months Current
Vikas Gupta
Also directs: Iol Speciality Chemicals Limited, Mayadevi Polycot Limited, Nm Merchantiles Limited and 1 more
Whole-Time Director 29 May 2015 11 Years 1 Months Current
Kushal Kumar Rana Whole-Time Director 04 Jun 2021 5 Years 1 Months Current
Sharad Tyagi
Also directs: Procter & Gamble Health Limited
Director 30 May 2022 4 Years 1 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Iol Chemicals And Pharmaceuticals Limited FY 2026 filings available

Iol Chemicals And Pharmaceuticals Limited reported revenue of ₹2,319.06 Cr (up 11.54% YoY) for FY 2026.

Revenue · FY 2026
₹2,319.06 Cr ▲ 11.54%
Profit · FY 2026
₹137.64 Cr ▲ 36.18%
Computed EBITDA · FY 2026
₹290.35 Cr ▲ 29.21%
Revenue₹ Cr · Consolidated01,0002,0003,000FY 2022: ₹2,184 Cr2,184FY 2022FY 2023: ₹2,217 Cr · +1.5% YoY2,217+1.5%FY 2023FY 2024: ₹2,133 Cr · -3.8% YoY2,133-3.8%FY 2024FY 2025: ₹2,079 Cr · -2.5% YoY2,079-2.5%FY 2025FY 2026: ₹2,319 Cr · +11.5% YoY2,319+11.5%FY 2026
Net Profit₹ Cr · Consolidated0100200FY 2022: ₹168 Cr168FY 2022FY 2023: ₹139 Cr · -17% YoY139-17%FY 2023FY 2024: ₹134 Cr · -3.4% YoY134-3.4%FY 2024FY 2025: ₹101 Cr · -24.8% YoY101-24.8%FY 2025FY 2026: ₹138 Cr · +36.2% YoY138+36.2%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0250500750Q1'25: ₹502 Cr · -10.8% YoY502-10.8%Q1'25Q2'25: ₹526 Cr · -3.6% YoY526-3.6%Q2'25Q3'25: ₹523 Cr · +0.6% YoY523+0.6%Q3'25Q4'25: ₹528 Cr · +4.7% YoY528+4.7%Q4'25Q1'26: ₹552 Cr · +9.8% YoY552+9.8%Q1'26Q2'26: ₹568 Cr · +7.9% YoY568+7.9%Q2'26Q3'26: ₹580 Cr · +10.9% YoY580+10.9%Q3'26Q4'26: ₹619 Cr · +17.4% YoY619+17.4%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Revenue from Operations ₹2,319.06 Cr ₹2,079.21 Cr ₹2,132.79 Cr ₹2,217.11 Cr ₹2,184.02 Cr
Other Income ₹21.38 Cr ₹22.41 Cr ₹30.07 Cr ₹25.61 Cr ₹32.04 Cr
Total Income ₹2,340.44 Cr ₹2,101.62 Cr ₹2,162.86 Cr ₹2,242.72 Cr ₹2,216.06 Cr
Cost of Materials Consumed ₹1,501.61 Cr ₹1,358.34 Cr ₹1,435.05 Cr ₹1,536.07 Cr ₹1,578.91 Cr
Purchases of Stock-in-Trade ₹4.02 Cr ₹0 ₹15 Lakh ₹29.22 Cr ₹43.9 Cr
Changes in Inventories -₹18.53 Cr ₹33.51 Cr -₹38.25 Cr -₹18.2 Cr -₹52.3 Cr
Employee Benefit Expense ₹248.26 Cr ₹216.57 Cr ₹201.02 Cr ₹168.21 Cr ₹141.3 Cr
Finance Costs ₹14.55 Cr ₹14.76 Cr ₹16.1 Cr ₹16.47 Cr ₹8.29 Cr
Depreciation & Amortisation ₹80.23 Cr ₹71.99 Cr ₹62.91 Cr ₹46.16 Cr ₹43.26 Cr
Other Expenses ₹314.73 Cr ₹268.49 Cr ₹304.23 Cr ₹276.14 Cr ₹213.92 Cr
Total Expenses ₹2,144.87 Cr ₹1,963.66 Cr ₹1,981.21 Cr ₹2,054.07 Cr ₹1,977.28 Cr
Profit Before Exceptional Items & Tax ₹195.57 Cr ₹137.96 Cr ₹181.65 Cr ₹188.65 Cr ₹238.78 Cr
Exceptional Items -₹11.21 Cr ₹0 ₹0 ₹0 -₹13.93 Cr
Profit Before Tax ₹184.36 Cr ₹137.96 Cr ₹181.65 Cr ₹188.65 Cr ₹224.85 Cr
Total Tax Expense ₹46.72 Cr ₹36.89 Cr ₹47.22 Cr ₹49.51 Cr ₹57.18 Cr
Net Profit ₹137.64 Cr ₹101.07 Cr ₹134.43 Cr ₹139.14 Cr ₹167.67 Cr
Other Comprehensive Income ₹2.6 Cr -₹1.44 Cr -₹1.29 Cr -₹20 Lakh -₹60 Lakh
Total Comprehensive Income ₹140.24 Cr ₹99.63 Cr ₹133.14 Cr ₹138.94 Cr ₹167.07 Cr
EBITDA (computed) ₹290.35 Cr ₹224.71 Cr ₹260.66 Cr ₹251.28 Cr ₹290.33 Cr
Basic EPS ₹4.69 ₹3.44 ₹22.90 ₹23.70 ₹28.56
Diluted EPS ₹4.69 ₹3.44 ₹22.90 ₹23.70 ₹28.56
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹2,586.95 Cr ₹2,382.07 Cr ₹2,244.4 Cr ₹2,022.13 Cr
Non-current Assets ₹1,359.32 Cr ₹1,230.73 Cr ₹1,124.63 Cr ₹1,101.74 Cr
Current Assets ₹1,227.63 Cr ₹1,151.34 Cr ₹1,119.77 Cr ₹920.39 Cr
Property, Plant & Equipment ₹1,165.38 Cr ₹1,158.37 Cr ₹921.56 Cr ₹751.02 Cr
Inventories ₹371.07 Cr ₹360.62 Cr ₹424.84 Cr ₹325.52 Cr
Trade Receivables ₹603.13 Cr ₹513.69 Cr ₹471.23 Cr ₹505.28 Cr
Cash & Equivalents ₹65.35 Cr ₹78.17 Cr ₹7.69 Cr ₹1.39 Cr
Equity (Net Worth) ₹1,798.55 Cr ₹1,687.66 Cr ₹1,611.51 Cr ₹1,507.72 Cr
Equity Share Capital ₹58.71 Cr ₹58.71 Cr ₹58.71 Cr ₹58.71 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹132 Cr ₹117.04 Cr ₹32.76 Cr ₹79.63 Cr
Total Debt (computed) ₹132 Cr ₹117.04 Cr ₹32.76 Cr ₹79.63 Cr
Current Liabilities ₹690.18 Cr ₹609.91 Cr ₹560 Cr ₹456.26 Cr
Total Liabilities ₹788.4 Cr ₹694.41 Cr ₹632.89 Cr ₹514.41 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹214.32 Cr ₹178.62 Cr ₹290.08 Cr ₹122.27 Cr ₹93.05 Cr
Investing Cash Flow -₹198.11 Cr -₹154.18 Cr -₹191.28 Cr -₹120 Cr -₹120.19 Cr
Financing Cash Flow -₹29.03 Cr ₹46.04 Cr -₹92.5 Cr -₹4.11 Cr -₹1.64 Cr
Capital Expenditure ₹172.99 Cr ₹213.55 Cr ₹274.17 Cr ₹211.82 Cr ₹153.29 Cr
Free Cash Flow (computed) ₹41.33 Cr -₹34.93 Cr ₹15.91 Cr -₹89.55 Cr -₹60.24 Cr
Dividends Paid ₹29.35 Cr ₹23.48 Cr ₹29.35 Cr ₹23.5 Cr ₹35.22 Cr
Net Change in Cash -₹12.82 Cr ₹70.48 Cr ₹6.3 Cr -₹1.84 Cr -₹28.78 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹619.45 Cr ₹580.39 Cr ₹567.53 Cr ₹551.69 Cr ₹527.78 Cr ₹523.3 Cr ₹525.75 Cr ₹502.38 Cr ₹503.92 Cr ₹520.39 Cr ₹545.3 Cr ₹563.18 Cr
Other Income ₹1.84 Cr ₹5.29 Cr ₹6.88 Cr ₹7.37 Cr ₹4.53 Cr ₹4.07 Cr ₹6.43 Cr ₹7.38 Cr ₹7.52 Cr ₹8.38 Cr ₹7.11 Cr ₹7.06 Cr
Total Income ₹621.29 Cr ₹585.68 Cr ₹574.41 Cr ₹559.06 Cr ₹532.31 Cr ₹527.37 Cr ₹532.18 Cr ₹509.76 Cr ₹511.44 Cr ₹528.77 Cr ₹552.41 Cr ₹570.24 Cr
Cost of Materials Consumed ₹401.66 Cr ₹356.7 Cr ₹366.7 Cr ₹376.55 Cr ₹347.61 Cr ₹335.96 Cr ₹351.75 Cr ₹323.02 Cr ₹349.3 Cr ₹358.06 Cr ₹350.99 Cr ₹376.7 Cr
Purchases of Stock-in-Trade ₹3.83 Cr ₹19 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹15 Lakh
Changes in Inventories -₹33.23 Cr ₹25.55 Cr ₹1.47 Cr -₹12.32 Cr -₹1.82 Cr ₹18.09 Cr ₹3.89 Cr ₹13.35 Cr -₹26.78 Cr -₹2.11 Cr ₹2.53 Cr -₹11.89 Cr
Employee Benefit Expense ₹70.33 Cr ₹56.93 Cr ₹63.35 Cr ₹57.65 Cr ₹52.39 Cr ₹52.43 Cr ₹58.7 Cr ₹53.05 Cr ₹49.65 Cr ₹48.29 Cr ₹48.99 Cr ₹54.09 Cr
Finance Costs ₹3.21 Cr ₹3.63 Cr ₹3.48 Cr ₹4.23 Cr ₹4.03 Cr ₹4.46 Cr ₹4.12 Cr ₹2.15 Cr ₹3.41 Cr ₹4.3 Cr ₹4.44 Cr ₹3.95 Cr
Depreciation & Amortisation ₹20.29 Cr ₹20.18 Cr ₹19.99 Cr ₹19.77 Cr ₹18.55 Cr ₹18.68 Cr ₹17.94 Cr ₹16.82 Cr ₹16.43 Cr ₹16.34 Cr ₹15.69 Cr ₹14.45 Cr
Other Expenses ₹84.39 Cr ₹83.74 Cr ₹78.93 Cr ₹67.67 Cr ₹66.85 Cr ₹69.95 Cr ₹69.84 Cr ₹61.85 Cr ₹82.23 Cr ₹71.8 Cr ₹78.59 Cr ₹71.61 Cr
Total Expenses ₹550.48 Cr ₹546.92 Cr ₹533.92 Cr ₹513.55 Cr ₹487.61 Cr ₹499.57 Cr ₹506.24 Cr ₹470.24 Cr ₹474.24 Cr ₹496.68 Cr ₹501.23 Cr ₹509.06 Cr
Profit Before Exceptional Items & Tax ₹70.81 Cr ₹38.76 Cr ₹40.49 Cr ₹45.51 Cr ₹44.7 Cr ₹27.8 Cr ₹25.94 Cr ₹39.52 Cr ₹37.2 Cr ₹32.09 Cr ₹51.18 Cr ₹61.18 Cr
Exceptional Items ₹0 -₹11.21 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹70.81 Cr ₹27.55 Cr ₹40.49 Cr ₹45.51 Cr ₹44.7 Cr ₹27.8 Cr ₹25.94 Cr ₹39.52 Cr ₹37.2 Cr ₹32.09 Cr ₹51.18 Cr ₹61.18 Cr
Total Tax Expense ₹17.65 Cr ₹6.97 Cr ₹10.52 Cr ₹11.58 Cr ₹13.28 Cr ₹7.27 Cr ₹6.79 Cr ₹9.55 Cr ₹9.58 Cr ₹9.01 Cr ₹13.31 Cr ₹15.32 Cr
Net Profit ₹53.16 Cr ₹20.58 Cr ₹29.97 Cr ₹33.93 Cr ₹31.42 Cr ₹20.53 Cr ₹19.15 Cr ₹29.97 Cr ₹27.62 Cr ₹23.08 Cr ₹37.87 Cr ₹45.86 Cr
Other Comprehensive Income ₹2.71 Cr ₹14 Lakh ₹39 Lakh -₹64 Lakh ₹2 Lakh -₹11 Lakh ₹8 Lakh -₹1.43 Cr ₹31 Lakh ₹11 Lakh -₹48 Lakh -₹1.23 Cr
Total Comprehensive Income ₹55.87 Cr ₹20.72 Cr ₹30.36 Cr ₹33.29 Cr ₹31.44 Cr ₹20.42 Cr ₹19.23 Cr ₹28.54 Cr ₹27.93 Cr ₹23.19 Cr ₹37.39 Cr ₹44.63 Cr
EBITDA (computed) ₹94.31 Cr ₹62.57 Cr ₹63.96 Cr ₹69.51 Cr ₹67.28 Cr ₹50.94 Cr ₹48 Cr ₹58.49 Cr ₹57.04 Cr ₹52.73 Cr ₹71.31 Cr ₹79.58 Cr
Basic EPS ₹1.81 ₹0.70 ₹1.02 ₹1.16 ₹1.07 ₹3.50 ₹3.26 ₹5.11 ₹4.71 ₹3.93 ₹6.45 ₹7.81
Diluted EPS ₹1.81 ₹0.70 ₹1.02 ₹1.16 ₹1.07 ₹3.50 ₹3.26 ₹5.11 ₹4.71 ₹3.93 ₹6.45 ₹7.81
Latest 12 quarters shown of 17 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Chemical ₹306.42 Cr ₹12.82 Cr ₹578.66 Cr ₹297.72 Cr
Pharmaceutical ₹374.51 Cr ₹62.23 Cr ₹1,512.64 Cr ₹196.6 Cr
Unallocated ₹1.84 Cr ₹0 ₹495.65 Cr ₹294.08 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Chemical ₹1,160.53 Cr ₹30.24 Cr - -
Pharmaceutical ₹1,396.25 Cr ₹172.27 Cr - -
Unallocated ₹21.38 Cr ₹0 - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹2,319.06 Cr ₹2,079.21 Cr ₹2,132.79 Cr ₹2,217.11 Cr ₹2,184.02 Cr ₹1,966.98 Cr ₹1,894.47 Cr
Other Income ₹21.28 Cr ₹22.4 Cr ₹30.07 Cr ₹25.57 Cr ₹32.04 Cr ₹24.3 Cr ₹16.02 Cr
Total Income ₹2,340.34 Cr ₹2,101.61 Cr ₹2,162.86 Cr ₹2,242.68 Cr ₹2,216.06 Cr ₹1,991.28 Cr ₹1,910.49 Cr
Cost of Materials Consumed ₹1,501.61 Cr ₹1,358.34 Cr ₹1,435.05 Cr ₹1,536.07 Cr ₹1,578.91 Cr ₹1,119.95 Cr ₹1,044.05 Cr
Purchases of Stock-in-Trade ₹4.02 Cr ₹0 ₹15 Lakh ₹29.22 Cr ₹43.9 Cr ₹0 ₹0
Changes in Inventories -₹18.53 Cr ₹33.51 Cr -₹38.25 Cr -₹18.2 Cr -₹52.3 Cr -₹17.11 Cr ₹20.96 Cr
Employee Benefit Expense ₹248.26 Cr ₹216.57 Cr ₹201.02 Cr ₹168.21 Cr ₹141.3 Cr ₹115.55 Cr ₹97.2 Cr
Finance Costs ₹14.55 Cr ₹14.76 Cr ₹16.1 Cr ₹16.47 Cr ₹8.29 Cr ₹5.83 Cr ₹20.93 Cr
Depreciation & Amortisation ₹80.17 Cr ₹71.92 Cr ₹62.85 Cr ₹46.13 Cr ₹43.26 Cr ₹38.92 Cr ₹35.73 Cr
Other Expenses ₹314.61 Cr ₹268.62 Cr ₹303.3 Cr ₹275.29 Cr ₹215.93 Cr ₹156.75 Cr ₹158.38 Cr
Total Expenses ₹2,144.69 Cr ₹1,963.72 Cr ₹1,980.22 Cr ₹2,053.19 Cr ₹1,979.29 Cr ₹1,419.89 Cr ₹1,377.25 Cr
Profit Before Exceptional Items & Tax ₹195.65 Cr ₹137.89 Cr ₹182.64 Cr ₹189.49 Cr ₹236.77 Cr ₹571.39 Cr ₹533.24 Cr
Exceptional Items -₹11.21 Cr ₹0 ₹0 ₹0 -₹13.93 Cr ₹0 ₹0
Profit Before Tax ₹184.44 Cr ₹137.89 Cr ₹182.64 Cr ₹189.49 Cr ₹222.84 Cr ₹571.39 Cr ₹533.24 Cr
Total Tax Expense ₹46.72 Cr ₹36.89 Cr ₹47.22 Cr ₹49.51 Cr ₹57.18 Cr ₹126.83 Cr ₹171.95 Cr
Net Profit ₹137.72 Cr ₹101 Cr ₹135.42 Cr ₹139.98 Cr ₹165.66 Cr ₹444.56 Cr ₹361.29 Cr
Other Comprehensive Income ₹2.6 Cr -₹1.44 Cr -₹1.29 Cr -₹20 Lakh -₹60 Lakh -₹2.14 Cr -₹1.52 Cr
Total Comprehensive Income ₹140.32 Cr ₹99.56 Cr ₹134.13 Cr ₹139.78 Cr ₹165.06 Cr ₹442.42 Cr ₹359.77 Cr
EBITDA (computed) ₹290.37 Cr ₹224.57 Cr ₹261.59 Cr ₹252.09 Cr ₹288.32 Cr ₹616.14 Cr ₹589.9 Cr
Basic EPS ₹4.69 ₹3.44 ₹23.07 ₹23.84 ₹28.22 ₹76.21 ₹63.51
Diluted EPS ₹4.69 ₹3.44 ₹23.07 ₹23.84 ₹28.22 ₹76.21 ₹63.38
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹2,586.72 Cr ₹2,381.78 Cr ₹2,243.97 Cr ₹2,020.61 Cr
Non-current Assets ₹1,359.21 Cr ₹1,230.66 Cr ₹1,124.49 Cr ₹1,101.54 Cr
Current Assets ₹1,227.51 Cr ₹1,151.12 Cr ₹1,119.48 Cr ₹919.07 Cr
Property, Plant & Equipment ₹1,165.07 Cr ₹1,158 Cr ₹921.12 Cr ₹750.52 Cr
Inventories ₹371.07 Cr ₹360.62 Cr ₹424.84 Cr ₹325.52 Cr
Trade Receivables ₹603.13 Cr ₹513.69 Cr ₹471.23 Cr ₹505.28 Cr
Cash & Equivalents ₹65.29 Cr ₹78.02 Cr ₹7.53 Cr ₹96 Lakh
Equity (Net Worth) ₹1,798.38 Cr ₹1,687.41 Cr ₹1,611.33 Cr ₹1,506.55 Cr
Equity Share Capital ₹58.71 Cr ₹58.71 Cr ₹58.71 Cr ₹58.71 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹132 Cr ₹117.04 Cr ₹32.76 Cr ₹79.63 Cr
Total Debt (computed) ₹132 Cr ₹117.04 Cr ₹32.76 Cr ₹79.63 Cr
Current Liabilities ₹690.12 Cr ₹609.87 Cr ₹559.75 Cr ₹455.91 Cr
Total Liabilities ₹788.34 Cr ₹694.37 Cr ₹632.64 Cr ₹514.06 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹214.42 Cr ₹178.68 Cr ₹290.76 Cr ₹123.14 Cr ₹91.04 Cr
Investing Cash Flow -₹198.12 Cr -₹154.23 Cr -₹191.69 Cr -₹119.19 Cr -₹120.29 Cr
Financing Cash Flow -₹29.03 Cr ₹46.04 Cr -₹92.5 Cr -₹4.11 Cr -₹1.64 Cr
Capital Expenditure ₹172.99 Cr ₹213.55 Cr ₹274.17 Cr ₹211.29 Cr ₹153.29 Cr
Free Cash Flow (computed) ₹41.43 Cr -₹34.87 Cr ₹16.59 Cr -₹88.15 Cr -₹62.25 Cr
Dividends Paid ₹29.35 Cr ₹23.48 Cr ₹29.35 Cr ₹23.5 Cr ₹35.22 Cr
Net Change in Cash -₹12.73 Cr ₹70.49 Cr ₹6.57 Cr -₹16 Lakh -₹30.89 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹619.45 Cr ₹580.39 Cr ₹567.53 Cr ₹551.69 Cr ₹527.78 Cr ₹523.3 Cr ₹525.75 Cr ₹502.38 Cr ₹503.92 Cr ₹520.39 Cr ₹545.3 Cr ₹563.18 Cr
Other Income ₹1.74 Cr ₹5.29 Cr ₹6.88 Cr ₹7.37 Cr ₹4.52 Cr ₹4.07 Cr ₹6.43 Cr ₹7.38 Cr ₹7.52 Cr ₹8.38 Cr ₹7.11 Cr ₹7.06 Cr
Total Income ₹621.19 Cr ₹585.68 Cr ₹574.41 Cr ₹559.06 Cr ₹532.3 Cr ₹527.37 Cr ₹532.18 Cr ₹509.76 Cr ₹511.44 Cr ₹528.77 Cr ₹552.41 Cr ₹570.24 Cr
Cost of Materials Consumed ₹401.66 Cr ₹356.7 Cr ₹366.7 Cr ₹376.55 Cr ₹347.61 Cr ₹335.96 Cr ₹351.75 Cr ₹323.02 Cr ₹349.3 Cr ₹358.06 Cr ₹350.99 Cr ₹376.7 Cr
Purchases of Stock-in-Trade ₹3.83 Cr ₹19 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹15 Lakh
Changes in Inventories -₹33.23 Cr ₹25.55 Cr ₹1.47 Cr -₹12.32 Cr -₹1.82 Cr ₹18.09 Cr ₹3.89 Cr ₹13.35 Cr -₹26.78 Cr -₹2.11 Cr ₹2.53 Cr -₹11.89 Cr
Employee Benefit Expense ₹70.33 Cr ₹56.93 Cr ₹63.35 Cr ₹57.65 Cr ₹52.39 Cr ₹52.43 Cr ₹58.7 Cr ₹53.05 Cr ₹49.65 Cr ₹48.29 Cr ₹48.99 Cr ₹54.09 Cr
Finance Costs ₹3.21 Cr ₹3.63 Cr ₹3.48 Cr ₹4.23 Cr ₹4.03 Cr ₹4.46 Cr ₹4.12 Cr ₹2.15 Cr ₹3.41 Cr ₹4.3 Cr ₹4.44 Cr ₹3.95 Cr
Depreciation & Amortisation ₹20.27 Cr ₹20.17 Cr ₹19.98 Cr ₹19.75 Cr ₹18.53 Cr ₹18.66 Cr ₹17.93 Cr ₹16.8 Cr ₹16.42 Cr ₹16.32 Cr ₹15.67 Cr ₹14.44 Cr
Other Expenses ₹84.29 Cr ₹83.75 Cr ₹78.91 Cr ₹67.66 Cr ₹66.66 Cr ₹69.95 Cr ₹69.85 Cr ₹62.16 Cr ₹81.67 Cr ₹71.67 Cr ₹78.69 Cr ₹71.27 Cr
Total Expenses ₹550.36 Cr ₹546.92 Cr ₹533.89 Cr ₹513.52 Cr ₹487.4 Cr ₹499.55 Cr ₹506.24 Cr ₹470.53 Cr ₹473.67 Cr ₹496.53 Cr ₹501.31 Cr ₹508.71 Cr
Profit Before Exceptional Items & Tax ₹70.83 Cr ₹38.76 Cr ₹40.52 Cr ₹45.54 Cr ₹44.9 Cr ₹27.82 Cr ₹25.94 Cr ₹39.23 Cr ₹37.77 Cr ₹32.24 Cr ₹51.1 Cr ₹61.53 Cr
Exceptional Items ₹0 -₹11.21 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹70.83 Cr ₹27.55 Cr ₹40.52 Cr ₹45.54 Cr ₹44.9 Cr ₹27.82 Cr ₹25.94 Cr ₹39.23 Cr ₹37.77 Cr ₹32.24 Cr ₹51.1 Cr ₹61.53 Cr
Total Tax Expense ₹17.65 Cr ₹6.97 Cr ₹10.52 Cr ₹11.58 Cr ₹13.28 Cr ₹7.27 Cr ₹6.79 Cr ₹9.55 Cr ₹9.58 Cr ₹9.01 Cr ₹13.31 Cr ₹15.32 Cr
Net Profit ₹53.18 Cr ₹20.58 Cr ₹30 Cr ₹33.96 Cr ₹31.62 Cr ₹20.55 Cr ₹19.15 Cr ₹29.68 Cr ₹28.19 Cr ₹23.23 Cr ₹37.79 Cr ₹46.21 Cr
Other Comprehensive Income ₹2.71 Cr ₹14 Lakh ₹39 Lakh -₹64 Lakh ₹2 Lakh -₹11 Lakh ₹8 Lakh -₹1.43 Cr ₹31 Lakh ₹11 Lakh -₹48 Lakh -₹1.23 Cr
Total Comprehensive Income ₹55.89 Cr ₹20.72 Cr ₹30.39 Cr ₹33.32 Cr ₹31.64 Cr ₹20.44 Cr ₹19.23 Cr ₹28.25 Cr ₹28.5 Cr ₹23.34 Cr ₹37.31 Cr ₹44.98 Cr
EBITDA (computed) ₹94.31 Cr ₹62.56 Cr ₹63.98 Cr ₹69.52 Cr ₹67.46 Cr ₹50.94 Cr ₹47.99 Cr ₹58.18 Cr ₹57.6 Cr ₹52.86 Cr ₹71.21 Cr ₹79.92 Cr
Basic EPS ₹1.81 ₹0.70 ₹1.02 ₹1.16 ₹1.08 ₹3.50 ₹3.26 ₹5.06 ₹4.80 ₹3.96 ₹6.44 ₹7.87
Diluted EPS ₹1.81 ₹0.70 ₹1.02 ₹1.16 ₹1.08 ₹3.50 ₹3.26 ₹5.06 ₹4.80 ₹3.96 ₹6.44 ₹7.87
Latest 12 quarters shown of 25 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Chemical ₹306.42 Cr ₹12.82 Cr ₹578.66 Cr ₹297.72 Cr
Pharmaceutical ₹374.51 Cr ₹62.23 Cr ₹1,512.64 Cr ₹196.6 Cr
Unallocated ₹1.74 Cr ₹0 ₹495.42 Cr ₹294.02 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Chemical ₹1,160.53 Cr ₹30.24 Cr - -
Pharmaceutical ₹1,396.25 Cr ₹172.27 Cr - -
Unallocated ₹21.28 Cr ₹0 - -
Want more history and ratios?
You're viewing the latest exchange-filed financials for Iol Chemicals And Pharmaceuticals Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Iol Chemicals And Pharmaceuticals Limited

As per the shareholding pattern filed with NSE for the quarter ended Jun 2026, promoters hold 62.28%, foreign institutional investors hold 4.87%, domestic institutional investors hold 0.43%, retail and other public shareholders hold 32.42% of Iol Chemicals And Pharmaceuticals Limited. The company had 119,311 shareholders on record.

Promoters: 62.28%DII (Domestic Institutional): 0.43%FII (Foreign Institutional): 4.87%Retail & Others: 32.42%
Jun 2026
QUARTER
62.28% Promoters
0.43% DII (Domestic Institutional)
4.87% FII (Foreign Institutional)
32.42% Retail & Others
Promoter holding - history
Now 62.28% · Jun 2026High 62.28% · Jun 2026Low 39.92% · Dec 2015
38%44.5%51%57.5%64%Dec 2015Jun 2018Dec 2020Jun 2023Dec 2025Dec 2015: 39.92%Mar 2016: 39.92%Jun 2016: 39.92%Sep 2016: 39.92%Dec 2016: 39.92%Mar 2017: 41.19%Jun 2017: 41.19%Sep 2017: 41.19%Dec 2017: 41.19%Mar 2018: 41.19%Jun 2018: 41.19%Sep 2018: 41.19%Dec 2018: 41.19%Mar 2019: 41.89%Jun 2019: 41.89%Sep 2019: 41.89%Dec 2019: 41.89%Mar 2020: 41.89%Jun 2020: 43.30%Sep 2020: 43.69%Dec 2020: 43.69%Mar 2021: 43.69%Jun 2021: 43.69%Sep 2021: 43.69%Dec 2021: 43.69%Mar 2022: 43.69%Jun 2022: 43.69%Sep 2022: 43.69%Dec 2022: 43.69%Mar 2023: 48.19%Jun 2023: 48.19%Sep 2023: 48.19%Dec 2023: 48.19%Mar 2024: 48.19%Jun 2024: 48.19%Sep 2024: 48.19%Dec 2024: 52.62%Mar 2025: 52.62%Jun 2025: 52.62%Sep 2025: 52.62%Dec 2025: 52.62%Mar 2026: 57.48%Jun 2026: 62.28%39.92%62.28%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
Promoters62.28%57.48%52.62%52.62%52.62%52.62%
Public37.72%42.52%47.38%47.38%47.38%47.38%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters57.48%52.62%48.19%48.19%43.69%43.69%41.89%41.89%41.19%41.19%39.92%
Public42.52%47.38%51.81%51.81%56.31%56.31%58.11%58.11%58.81%58.81%60.08%
Promoter change (YoY, %pts)+4.86+4.43+0.00+4.50+0.00+1.80+0.00+0.70+0.00+1.27-

Board & Governance of Iol Chemicals And Pharmaceuticals Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Iol Chemicals And Pharmaceuticals Limited has 8 directors - 4 independent and 4 executive. The board is chaired by Rajender Mohan Malla.

DirectorPositionOn board sinceListed boards
Rajender Mohan Malla Non-Executive - Independent Director · Chairperson 2019-02-06 5
Varinder Gupta Executive Director · MD 1986-11-13 1
Vikas Gupta Executive Director 2015-05-29 1
Abhiraj Gupta Executive Director 2023-04-03 1
Kushal Kumar Rana Executive Director 2021-06-04 1
Harpal Singh Non-Executive - Independent Director 2019-02-06 2
Sharad Tyagi Non-Executive - Independent Director 2022-05-30 2
Rajni Jha Non-Executive - Independent Director 2024-10-28 1
Board Committees
CommitteeMembers
Audit Committee Harpal Singh (Chairperson), Sharad Tyagi, Rajni Jha, Kushal Kumar Rana
Nomination and remuneration committee Harpal Singh (Chairperson), Rajender Mohan Malla, Sharad Tyagi
Stakeholders Relationship Committee Sharad Tyagi (Chairperson), Vikas Gupta, Rajni Jha
Risk Management Committee Harpal Singh (Chairperson), Kushal Kumar Rana, Abhiraj Gupta, Sharad Tyagi, Pardeep Kumar Khanna
Corporate Social Responsibility Committee Rajender Mohan Malla (Chairperson), Vikas Gupta, Harpal Singh, Abhiraj Gupta, Sharad Tyagi

Group Structure of Iol Chemicals And Pharmaceuticals Limited

Iol Chemicals And Pharmaceuticals Limited has 3 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Iol Chemicals And Pharmaceuticals Limited's business expansion strategy and organizational complexity.

3
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Iol Speciality Chemicals Limited U24290PB2022PLC056275 -
Iol Life Sciences Limited U24299PB2022PLC056233 -
Iol-Foundation U85300PB2022NPL055428 -

Showing major subsidiaries. Total: 3.

Charges & Borrowings of Iol Chemicals And Pharmaceuticals Limited

Open charges
₹700 Cr
Satisfied charges
₹1,487.01 Cr
Breakdown by lending institutions
Others₹700.00 Cr
Latest charge details
DateLenderAmountStatus
21 Jun 2016 Others ₹700 Cr Open
31 May 2016 Others ₹15 Cr Satisfied
23 Mar 2015 Others ₹30.71 Cr Satisfied
31 Dec 2014 Punjab National Bank ₹65.12 Cr Satisfied
30 Jun 2014 Punjab National Bank ₹162.4 Cr Satisfied

Total charge records: 57 View all charges

Employees and EPFO Compliance at Iol Chemicals And Pharmaceuticals Limited

Iol Chemicals And Pharmaceuticals Limited has a workforce of 2,778 employees as of Apr 01, 2024.

Employee count
2,778
Active EPFO establishments
1
Employee growth
3.62%
Premium access

Employee and EPFO history for Iol Chemicals And Pharmaceuticals Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Iol Chemicals And Pharmaceuticals Limited

Premium access

GST registrations and filing compliance for Iol Chemicals And Pharmaceuticals Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Iol Chemicals And Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Iol Chemicals And Pharmaceuticals Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Iol Chemicals And Pharmaceuticals Limited

Premium access

MSME payment history for Iol Chemicals And Pharmaceuticals Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Iol Chemicals And Pharmaceuticals Limited

Premium access

Corporate group structure for Iol Chemicals And Pharmaceuticals Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Iol Chemicals And Pharmaceuticals Limited

Premium access

MCA filings and documents for Iol Chemicals And Pharmaceuticals Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Iol Chemicals And Pharmaceuticals Limited

Activity
22 Aug 2025
Iol Chemicals And Pharmaceuticals Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records.
Activity
31 Mar 2025
Iol Chemicals And Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Directors
28 Oct 2024
Rajni Jha was appointed as a Director on 28 Oct 2024 & has been associated with this company since 1 year 8 months.
Charges
18 Sep 2024
A charge with Others of Rs. 700.00 Cr registered on 21 Jun 2016 with Charge ID 100037862 was modified on 18 Sep 2024.
Directors
03 Apr 2023
Abhiraj Gupta was appointed as a Whole-time director on 03 Apr 2023 & has been associated with this company since 3 years 3 months.
Directors
30 May 2022
Sharad Tyagi was appointed as a Director on 30 May 2022 & has been associated with this company since 4 years 1 month.

Recent News on Iol Chemicals And Pharmaceuticals Limited

Frequently Asked Questions about Iol Chemicals And Pharmaceuticals Limited

Iol Chemicals And Pharmaceuticals Limited is an active public limited company in the pharma sector based in Barnala, Punjab, India. It was incorporated on 29 September 1986 (40+ years old) and is registered under CIN L24116PB1986PLC007030. Listed on BSE: 524164 and NSE: IOLCP. The company has 2,778 employees.

Iol Chemicals And Pharmaceuticals Limited reported revenue of ₹2,319.06 Cr for FY 2026 (up 11.54% YoY) based on consolidated NSE filings.

The current directors of Iol Chemicals And Pharmaceuticals Limited are:

The primary industry of Iol Chemicals And Pharmaceuticals Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Iol Chemicals And Pharmaceuticals Limited is listed on both BSE (code: 524164) and NSE (symbol: IOLCP).

Iol Chemicals And Pharmaceuticals Limited can be reached at the registered office: Village & Post Office – Handiaya Fatehgarh Chhanna Road Tehsil & District – Barnala, Punjab, India – 148107, or through the website iolcp.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available